| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| Gardenine;[2aS-(2aalpha,4aalpha,7aalpha,7balpha)]-2,2a,4a,7,7a,7b-六氢-2a-羟基-1-氧杂-7-氮杂环戊并[cd]茚-5-羧酸甲酯 | Gardenine | 139682-36-3 | C11H13NO4 |
| GarcinoneC;1,3,6,7-四羟基-8-(3-羟基-3-甲基丁基)-2-(3-甲基-2-丁烯-1-基)-9H-呫吨-9-酮 | garcinone C | 76996-27-5 | C23H26O7 |
| GYKI52466,盐酸盐 | GYKI 52466 hydrochloride | 192065-56-8 | C17H16ClN3O2 |
| GYKI-53655水合物 | 5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide;hydron;chloride | 143692-48-2 | C19H21ClN4O3 |
| GW627368X抑制剂 | N-(benzenesulfonyl)-2-[4-(4,9-diethoxy-3-oxo-1H-benzo[f]isoindol-2-yl)phenyl]acetamide | 439288-66-1 | C30H28N2O6S |
| GW405833盐酸盐 | (2,3-dichlorophenyl)(5-methoxy-2-methyl-3-(2-morpholinoethyl)-1H-indol-1-yl)methanone | 180002-83-9 | C23H24Cl2N2O3 |
| GTx-134; 2-[4-[[(2R)-3-(2,4-二甲基苯氧基)-2-羟基丙基]氨基]-1,2-二氢-2-氧代-3-吡啶基]-6,7-二氢-6-[1-[2-(甲磺酰基)乙基]-4-哌啶基]吡咯并[3,4-f]苯并咪唑-5(3H)-酮 | 2-{4-[(R)-3-(2,4-dimethylphenoxy)-2-hydroxypropylamino]-2-oxo-1,2-dihydropyridin-3-yl}-6-[1-(2-methanesulfonylethyl)piperidin-4-yl]-6,7-dihydro-3H-1,3,6-triaza-s-indacen-5-one | 1008448-19-8 | C33H40N6O6S |
| GSKPERK抑制剂 | 1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2,3-dihydro-1H-indol-1-yl]-2-[3-fluoro-5-(trifluoromethyl)phenyl]ethanone | 1337531-89-1 | C24H19F4N5O |
| GSK789472盐酸盐 | 1-Phenyl-3-(piperidin-2-ylmethyl)imidazolidin-2-one hydrochloride | 1257326-24-1 | C15H22ClN3O |
| GSK256066三氟乙酸盐 | GSK256066 2,2,2-trifluoroacetic acid | 1415560-64-3 | C29H27F3N4O7S |
| GSK2334470游离态 | GKS2334470 | 1227911-45-6 | C25H34N8O |
| GSK2193874游离态 | GSK2193874 | 1336960-13-4 | C37H38BrF3N4O |
| GSK-3抑制剂(LY2090314) | 7-(2,5-dihydro-4-imidazo[1,2-a]pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo[3,2,1-jk][1,4]benzodiazepine | 603288-22-8 | C28H25FN6O3 |
| GSK-3beta 抑制剂 XI | GSK-3b Inhibitor XI | 626604-39-5 | C18H15N5O3 |
| GSK 525762A; (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-a][1,4]苯并二氮杂卓-4-乙酰胺 | I-BET762 | 1260907-17-2 | C22H22ClN5O2 |
| GSK 189254; 6-[(3-环丁基-2,3,4,5-四氢-1H-3-苯并氮杂卓-7-基)氧基]-N-甲基-3-吡啶甲酰胺盐酸盐 | [3H]-GSK189254 | 945493-87-8 | C21H25N3O2*ClH |
| GSK 1292263 盐酸盐 | 5-[({1-[3-(1-Methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methyl)oxy]-2-[4-(methylsulfonyl)phenyl]pyridine hydrochloride | 1032824-54-6 | C23H28N4O4S*ClH |
| GSK 1059615; (5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 | GSK1059615 | 958852-01-2 | C18H11N3O2S |
| GRANULAR BLUE 粒蓝相似物 | 2-<4-(4-Amidinophenoxy)phenyl>indol-6-carboxamidin-dihydrochlorid | 55453-00-4 | C22H19N5O*2ClH |
| GPR84拮抗剂8 | 2-([1,4]dioxan-2-ylmethoxy)-9-(pyridin-2-ylmethoxy)-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one | 1445846-30-9 | C23H23N3O5 |
| GPR109A受体激动剂(MK-0354) | MK-0354 | 851776-28-8 | C7H8N6 |
| GNF179代谢物 | 2-(4-Fluorophenyl)-8,8-dimethyl-5,6,7,8-tetrahydroimidazo[1,2-A]pyrazine | 1310455-86-7 | C14H16FN3 |
| GNE-495游离态 | 8-amino-N-(1-(cyclopropanecarbonyl)azetidin-3-yl)-2-(3-fluorophenyl)-1,7-naphthyridine-5-carboxamide | 1449277-10-4 | C22H20FN5O2 |
| GNE-477抑制剂 | GNE-477 | 1032754-81-6 | C21H28N8O3S2 |
| GNE-0877抑制剂 | 2-methyl-2-(3-methyl-4-((4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1H-pyrazol-1-yl)propanenitrile | 1374828-69-9 | C14H16F3N7 |
| GLPG0187,一种广谱的INTEGRIN受体拮抗剂,具有抗肿瘤活性 | L-Alanine, 3-((2,5-dimethyl-6-(4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)-1-piperidinyl)-4-pyrimidinyl)amino)-N-((4-methoxyphenyl)sulfonyl) | 1320346-97-1 | C29H37N7O5S |
| GLPG-0634 中间体 | N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | 1142943-96-1 | C10H9BrN4O |
| GJ103游离 | 2-((4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid | 1459687-89-8 | C16H14N4O3S |
| GJ-103钠盐 | sodium 2-((4-(3-methoxyphenyl)-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl)thio)acetate | 1459687-96-7 | C16H13N4O3S*Na |
| GENZ-644282抑制剂 | 2,3-dimethoxy-12-(2-(methylamino)ethyl)[1,3]dioxolo[4',5':4,5]-benzo[1,2-h]benzo[c][1,6]naphthyridin-13(12H)-one | 529488-28-6 | C22H21N3O5 |
| GDC-0349; N-Ethyl-N'-[4-[5,6,7,8-四氢-4-[(3S)-3-甲基-4-吗啉基]-7-(3-氧杂环丁基)吡啶并[3,4-d]嘧啶-2-基]苯基]脲 | (S)-1-ethyl-3-(4-(4-(3-methylmorpholino)-7-(oxetan-3-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-2-yl)phenyl)urea | 1207360-89-1 | C24H32N6O3 |
| GALUNISERTIB中间体 | 4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carbonitrile | 924898-13-5 | C22H17N5 |
| G9A和PRC2抑制剂(BRD9539) | 2-benzamido-1-(3-phenylpropyl)-1H-1,3-benzodiazole-5-carboxylic acid | 1374601-41-8 | C24H21N3O3 |
| Fagomine; 桑叶生物碱; (2R,3R,4R)-2-羟甲基哌啶-3,4-二醇 | D-fagomine | 53185-12-9 | C6H13NO3 |
| FRAX1036游离态 | Frax1036 | 1432908-05-8 | C28H32ClN7O |
| FR180204,一种ATP-竞争性的选择性的ERK抑制剂 | FR180204 | 865362-74-9 | C18H13N7 |
| FR167653硫酸盐 | FR167653 | 158876-66-5 | C24H18FN5O2*H2O4S |
| FP-生物素 | FP-biotin | 259270-28-5 | C27H50FN4O5PS |
| FMOC-L-1,2,3,4-四氢-Β-咔啉-3-羧酸 | N-Fmoc-Tpi-OH | 204322-23-6 | C27H22N2O4 |
| FLUO3五胺盐 | Fluo-3 (pentaammonium) | —— | C36H45Cl2N7O13 |
| FGFR抑制剂(NVP-BGJ398) | BGJ398 | 872511-34-7 | C26H31Cl2N7O3 |
| FGFR1酪氨酸激酶抑制剂(PD-166866) | PD 166866 | 192705-79-6 | C20H24N6O3 |
| FCLA自由酸[化学发光试剂] | 2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)-5-[({2-[4-(2-methyl-3-oxo-3,7-dihydroimidazo[1,2-a]pyrazin-6-yl)phenoxy]ethyl}carbamothioyl)amino]benzoic acid | 133118-06-6 | C36H27N5O7S |
| FAVIPIRAVIR杂质14 | 3-chloro-6-fluoro-2-pyrazinecarbonitrile | 356783-49-8 | C5HClFN3 |
| FAM炔烃6异构体 | 6-(prop-2-yn-1-yl)carbamoylfluorescein | 478801-49-9 | C24H15NO6 |
| FAM叠氮化物,6-异构体 | N-(3-azidoprop-1-yl)fluoresceinyl-6-carboxamide | 1386385-76-7 | C24H18N4O6 |
| F1-20蛋白质 | 3-Ethyl-2-methylquinoxalin-5-amine | 126987-75-5 | C11H13N3 |
| F-氟离子探针(叠氮) | 1-(3',6'-Bis(ethylamino)-2',7'-dimethyl-3-oxospiro[isoindoline-1,9'-xanthen]-2-yl)-3-phenylurea | 957493-98-0 | C33H33N5O3 |
| Ethyl 5-氨基-4-氰基-3-甲基-2-噻吩羧酸乙酯 | ethyl 5-amino-4-cyano-3-methylthiophene-2-carboxylate | 23903-46-0 | C9H10N2O2S |
| Esomeprazole镁盐水合物 | (S)-Omeprazole magnesium;(-)-Omeprazole magnesium | 668985-31-7 | C34H38MgN6O7S2 |